Pharmaceuticals Trio Draw Buy Ratings Ahead of 2026 Catalysts
A trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
Discover the smartest strategies for using a rewards credit card. Learn how to maximize benefits and save on your expenses.
27,792 articlesA trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
A year after Nordstrom’s private move, the retailer reports stronger sales and renewed store energy. The focus on bea...
Chewy rode a brighter sales outlook to a rally in its stock, with the company signaling durable demand for pet care d...
Hims & Hers is set to report Q1 earnings after the close as investors weigh a rebound in shares and the pace of cash ...
A week of policy chatter and market moves highlights a shift in China’s AI chip supply. While the president trump pus...
SpaceX plans a June IPO that would place a second Musk-led company in the public eye, raising questions about how muc...
A line in SpaceX's draft filings has sparked market chatter for its sci-fi tone. The phrase elon musk slipped now dom...
Analysts are weighing a path for synopsys stock $600 march targets as AI-driven chip design demand grows, even as deb...
SpaceX’s public debut reframes who wins in venture capital, with Founders Fund and Andreessen Horowitz among the marq...
A famed chart technician says memory stocks have stretched too far, urging investors to take profits now as signs of ...
A broad crypto rebound is lifting Coinbase as the company pivots toward subscriptions and services. Analysts see upsi...
A rebound appears to be taking shape in crushed software stocks as earnings from marquee players hint AI cannibalizat...